Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

State of health in China - statistics & facts

China has achieved a substantial improvement in overall public health, in tandem with the nation’s economic progress over past decades. Currently, the country has a public healthcare system which covers 90 percent of its vast population. Along with a rising living standard, people in China are living longer with better access to more affordable and higher quality health care services. While prevention of infectious diseases has been effective, other emerging public health issues, such as an aging population and chronic illness, will be the primary focuses of China in the coming years.

Re-engineering the medical care system

Aiming at providing all citizens with equal access to basic health care and financial protection, the Chinese government launched a healthcare system reform in 2009. Major efforts have been made in introducing cost-effective public health programs, establishing a universal social health insurance scheme, and strengthening infrastructure. These policies have largely reduced out-of-pocket (OOP) health payments with government subsidies, though gaps still remain in quality of care which varies with socioeconomic status and region.

The epidemiological transition

China has also witnessed a progressive shift in the health burden from communicable to chronic non-communicable diseases (NCDs). In terms of incidence rate, influenza, hand, foot, and mouth disease (HFMD), and infectious diarrhea were the most occurring infectious diseases. Since 2008, HIV/AIDS has been the deadliest disease in the group, followed by tuberculosis, hepatitis A, and hepatitis B. Overall, communicable diseases were responsible for 1.81 deaths per 100,000 population across the country in 2019.

The rapid aging population and the rise of NCDs have become a growing concern in China, with cancers, heart diseases, and cerebrovascular disease being the main underlying death causes. Due to the discrepancies in modernization level, demographics, and healthcare resources, the chronic illness trends in urban areas vary greatly from that of rural areas. Furthermore, the mortality rate of some diseases in rural China can be much higher than that in urban area.

The headwinds of NCDs and COVID-19

Given that unhealthy diet, physical inactivity, and obesity problems have become more common, more Chinese young people have hidden illness, especially cardiovascular disease and diabetes mellitus. Along with an estimated elderly population of 250 million in 2020, the country is facing a pressing demand for long term health care of patients with NCDs, which would push the annual healthcare expenditure to above 1.5 trillion U.S. dollars by 2024. In addition, the ongoing coronavirus (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), will continue to pose public health challenges in terms of virus tracking, testing, and vaccination. Despite being the first to roll out a mass vaccination program, it is still unclear whether China can achieve herd immunization by the end of 2021.

Key figures

The most important key figures provide you with a compact summary of the topic of "State of health in China" and take you straight to the corresponding statistics.

Women's health

Men's health

Children's health

Interesting statistics

In the following 5 chapters, you will quickly find the {amountStatistics} most important statistics relating to "State of health in China".

State of health in China

Dossier on the topic

All important statistics are prepared by our experts – available for direct download as PPT & PDF!
TOP SELLER

State of health in China - statistics & facts

China has achieved a substantial improvement in overall public health, in tandem with the nation’s economic progress over past decades. Currently, the country has a public healthcare system which covers 90 percent of its vast population. Along with a rising living standard, people in China are living longer with better access to more affordable and higher quality health care services. While prevention of infectious diseases has been effective, other emerging public health issues, such as an aging population and chronic illness, will be the primary focuses of China in the coming years.

Re-engineering the medical care system

Aiming at providing all citizens with equal access to basic health care and financial protection, the Chinese government launched a healthcare system reform in 2009. Major efforts have been made in introducing cost-effective public health programs, establishing a universal social health insurance scheme, and strengthening infrastructure. These policies have largely reduced out-of-pocket (OOP) health payments with government subsidies, though gaps still remain in quality of care which varies with socioeconomic status and region.

The epidemiological transition

China has also witnessed a progressive shift in the health burden from communicable to chronic non-communicable diseases (NCDs). In terms of incidence rate, influenza, hand, foot, and mouth disease (HFMD), and infectious diarrhea were the most occurring infectious diseases. Since 2008, HIV/AIDS has been the deadliest disease in the group, followed by tuberculosis, hepatitis A, and hepatitis B. Overall, communicable diseases were responsible for 1.81 deaths per 100,000 population across the country in 2019.

The rapid aging population and the rise of NCDs have become a growing concern in China, with cancers, heart diseases, and cerebrovascular disease being the main underlying death causes. Due to the discrepancies in modernization level, demographics, and healthcare resources, the chronic illness trends in urban areas vary greatly from that of rural areas. Furthermore, the mortality rate of some diseases in rural China can be much higher than that in urban area.

The headwinds of NCDs and COVID-19

Given that unhealthy diet, physical inactivity, and obesity problems have become more common, more Chinese young people have hidden illness, especially cardiovascular disease and diabetes mellitus. Along with an estimated elderly population of 250 million in 2020, the country is facing a pressing demand for long term health care of patients with NCDs, which would push the annual healthcare expenditure to above 1.5 trillion U.S. dollars by 2024. In addition, the ongoing coronavirus (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), will continue to pose public health challenges in terms of virus tracking, testing, and vaccination. Despite being the first to roll out a mass vaccination program, it is still unclear whether China can achieve herd immunization by the end of 2021.

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Hadley Ward
Hadley Ward
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Ziyan Zhang
Ziyan Zhang
Customer Relations– Contact (Asia)

Mon - Fri, 11:30am - 10pm (IST)

Contact Kisara Mizuno
Kisara Mizuno
Customer Success Manager– Contact (Asia)

Mon - Fri, 9:30am - 5:30pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Catalina Rodriguez
Catalina Rodriguez
Key Account Manager - LAC– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)